S?rensen
發(fā)表于10分鐘前
回復
Fresco（Pilot）等 : 中新網北京1月10日電(韋香惠)9日，國務院聯(lián)防聯(lián)控機制就第十版診療方有關情況舉行發(fā)布會。國衛(wèi)生健康委新聞發(fā)言人、傳司副司長米鋒表示，醫(yī)救治是新冠疫情防控工作當務之急，做好診療關口移和重癥患者救治是重要力點。上海社區(qū)衛(wèi)生服務心持續(xù)擴容增能 殷立勤 攝新版診療方案進一步豐診斷和治療手段國家衛(wèi)生康委醫(yī)療應急司司長郭燕介紹，在診斷標準上，將冠病毒的抗原檢測陽性納了診斷標準，主要考慮是原檢測對病毒載量高的感者有非常好的檢測靈敏度特別是隨著抗原檢測技術斷優(yōu)化和成熟，因此新冠毒感染者特別是病毒載量的感染者檢出率比較高。時，抗原檢測非常方便，單易行，方便感染者在家進行自測。在臨床救治方，國家衛(wèi)健委充分借鑒三來取得的寶貴經驗，一是強關口前移；二是進一步范重癥救治；三是堅持中醫(yī)結合；四是進一步強化冠病毒感染與基礎疾病共理念。醫(yī)護人員為市民進氧飽和度檢測。 殷立勤 攝臨床分型為何取消普通，增加中型郭燕紅解釋，型定義是持續(xù)高熱大于3天，在靜息狀態(tài)下吸空氣的氧飽和度要大于93%，影像學可見特征性的新冠病感染肺炎表現(xiàn)，但是它比型，也就是氧飽和度小于93%的程度要輕，這類病例歸類于中型。她表示，第版診療方案的調整是根據(jù)染者病情的嚴重程度，分輕型、中型、重型和危重，更加符合臨床實際。臨分型調整以后，也更加有于醫(yī)務人員對患者的病情行綜合研判，并給予綜合治療措施。醫(yī)護人員在CT掃描室?guī)椭忻襁M行拍片 殷立勤 攝高危人群為何由60歲以上調為65歲以上第十版診療方案中的重和危重型高危人群的判定準，年齡從第九版的大于60歲改成了大于65歲。對此，北京大學第一醫(yī)院感疾病科主任王貴強解釋，于這次微調，在臨床實踐，確實發(fā)現(xiàn)65歲以上的患有基礎病、尤其沒有打疫的人群重癥化和危重癥比更高，目前臨床上也發(fā)現(xiàn)這樣的現(xiàn)象，所以這次診方案進行了微調?！安还?0歲還是65歲，我們都要強調伴有基礎病的、沒有疫苗的更需要關注。”王強表示，希望在臨床實踐將這些高風險人群納入管，早期干預和觀察，發(fā)現(xiàn)題及時轉送上級醫(yī)院進行一步救治，最大限度降低癥和死亡的風險。村衛(wèi)生在衛(wèi)生室準備中藥與縣鄉(xiāng)務人員及村干上門開展巡服務?！堑萝?攝針對“陽康”后不適，提出三種療方案首都醫(yī)科大學附屬京中醫(yī)醫(yī)院院長劉清泉提，每一位患者都十分關注陽康”后的不適，第十版案根據(jù)奧密克戎變異株的床特征提出了三個狀態(tài)的療方案。他介紹，一是針乏力伴有脾胃功能虛弱，供了經典名方六君子湯治；二是針對乏力伴易出汗心慌胸悶等不適，推薦了參麥門冬湯、竹葉石膏湯經典名方；三是針對目前常見的咳嗽痰少等不適，案推薦了射干麻黃湯。劉泉表示，第十版方案非常注核酸、抗原轉陰后的諸不適，尤其是更加適用于密克戎變異株感染轉陰后康復治療。(完)
魯?shù)婪颉じ穸鞯?img style="display: inline-block; vertical-align: middle;margin-left: 6px;height: 16px;font-size: 0;" width="24" height="16" src="/img/daa01c3d7b4ad5cf.jpg">
發(fā)表于8小時前
回復
蒂莫西·銳科特 : ??齊魯網·閃新聞1月10日訊?為嚴厲打擊各違法犯罪活動，中整治各類安全患，確保歲末年全區(qū)社會治安大持續(xù)穩(wěn)定，在第個中國人民警察到來之際，1月10日，棗莊高新區(qū)在人才公園舉行平安一號”冬春嚴打整治啟動儀。到場的150余名警力警容嚴整精神煥發(fā)，治安邏車、警用摩托整齊列隊、蓄勢發(fā)，全面展示出新公安強大的應處突力量和維護區(qū)社會大局平安定的堅定信心。式結束后，由裝車、PTU、鐵騎、警車等裝備組的巡防隊伍，分奔赴各執(zhí)勤點進清查，以雷霆之開展了警車集中巡防行動。閃電聞記者 劉印紅 ?高新臺 劉雅麗 報道 棗莊新聞 山東省棗莊市 編輯： 劉印紅 賈曉宇 張潔 閱讀量：0
游曉錦
發(fā)表于4小時前
回復
Khalil : Medical workers run intravenous drips for patients at the fever clinic of China-Japan Friendship hospital in Beijing. [Photo by Wang Jing/chinadaily.com.cn]Patients needing treatment for COVID-19 will not have to foot pricey bills for hospitalization out of their own pockets until at least the end of March, according to authorities.Additionally, outpatient costs will be more generously refunded if incurred at smaller hospitals serving vast rural areas, they added.The policies were outlined in a circular released on Saturday by the National Healthcare Security Administration, the Ministry of Finance, the National Health Commission and the National Administration for Disease Prevention and Control.For the last few years, the State has settled all expenses for the diagnosis and treatment of COVID-19 at centralized isolation facilities.Payment liability issues were only brought to the fore early last month, when health authorities allowed patients to be treated at any hospital of their choice.The circular said the State will continue to pay for hospitalization costs until at least March 31, as long as patients conform to the diagnosis and treatment plan for novel coronavirus infections, as COVID-19 has been officially known in China since Dec 26. The disease was previously called novel coronavirus pneumonia.Hospitalization costs, usually incurred by older patients in critical condition, will be collectively paid by the national medical aid program for families in financial difficulty, local finance authorities, and two State-run healthcare plans with almost universal coverage on the mainland — basic medical insurance and insurance for severe illnesses. Central finance pledged it will give compensation of up to 60 percent of local finance payment liabilities.However, the liabilities for outpatient spending vary.The circular said that COVID-19 patients seeking medical advice at Grade 1 hospitals, or grassroots medical institutions such as township hospitals, will have at least 70 percent of their spending covered by the State, as part of an incentive for patients to avoid busier hospitals in major cities.The exact ratio will be determined by local medical insurance and finance departments depending on the state of their insurance funds."In principle, local authorities do not set thresholds for reimbursable costs or cap the refunds at grassroots medical institutions."In comparison, spending at higher-level hospitals — including for outpatient services and emergency treatment — will be reimbursed at the same rate as other Class B infectious diseases, which are constrained by a reimbursement threshold and a refund cap, it said.Places facing shortages of medications are allowed to add more drugs to the catalog of reimbursable medicines, the circular added.According to a 2020 report released by the State Council Information Office, the cost of treatment per COVID-19 patient averaged 23,000 yuan (,300).The cost of treating critically ill patients was usually in excess of 150,000 yuan, with some cases costing as much as several million yuan.Before the nationwide reimbursement policy was unveiled, local authorities were racing to devise their own rules to ease the financial burden on those suffering from COVID-19.For example, Anhui province published a circular on Dec 29 stipulating that 70 percent of outpatient costs and bills for emergency treatment will be reimbursed. The rules do not set thresholds for reimbursable costs or cap refunds and apply to both rural and urban hospitals in the province.In Jinjiang, Fujian province, authorities said that 70 percent of outpatient costs will be reimbursed at rural hospitals, compared with just 50 percent in urban ones. The city set a 420 yuan refund cap for spending at rural hospitals, compared with 50 yuan in urban hospitals.Places including Beijing, and Henan, Hubei and Yunnan provinces in December temporarily added a mix of traditional Chinese medicines, antiviral drugs and over-the-counter medications such as fever reducers and cold capsules to their catalog of medicines covered by State-run healthcare plans. Here is shan dong 編輯： 宋基金 閱讀量：615
